Chief Execuitive Officer at Envy Medical, Inc.
Greater Los Angeles Area
Chief Execuitive Officer at Envy Medical, Inc.
Greater Los Angeles Area
Curtis A. Cluff was named Chief Executive Officer of Envy Medical, Inc. in June 2009. Cluff brings over 15 years of executive operations and finance experience, from private equity startup through Fortune-500 sized corporations. Prior to joining Envy, Mr. Cluff was the President and COO for Colorescience Inc., establishing their medical channel strategy, and international presence from 2007 to 2009. From 2002 through 2007 Mr. Cluff served in a number of senior executive roles for Obagi Medical Product, Inc.'s, including Executive Vice President of Operations & Corporate Development, Interim President, and CFO. During this time, Mr. Cluff was a primary architect in building the company from a small private venture into the leading professional skincare brand in the United States, successfully taking the company public in 2006. Prior to that, Cluff served as the CFO of Beyond Corporation from 2000 to 2002, and as a Vice President & Senior Financial Officer for Merisel Inc., a fortune 500 technology distribution company from 1996 to 2000. Prior to his time with Merisel Inc., Mr. Cluff served from 1994 to 1996 as the Senior Financial Controller for the U.S. Pacific division of Westburne Inc. (now part of Rexel S.A.), the largest North American integrated wholesale distributor of construction, industrial and commercial supplies.
Mr. Cluff began his career with Deloitte and Touche, LLP's Audit and Advisory Services group, specializing in distribution and high-tech manufacturing. Mr. Cluff is a CPA and received his B.S. in Business Administration from California Polytechnic University.
medical products, consumer products, distribution, international sales & marketing, pre-IPO positioning, IPO, operations
(Privately Held; Biotechnology industry)
June 2009 — Present (2 months)
Envy’s mission is to offer highly effective noninvasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company's lead products include SilkPeel™, a breakthrough system that combines precision non-invasive exfoliation with Dermalinfusion™, deep delivery of a diverse set of skin-specific solutions, to improve and revitalize the skin.
The Company also owns exclusive rights to Lumixyl™. Developed by Dr. Basil Hantash’s team of dermatological researchers out of Stanford University, this ground-breaking technology is the only peptide clinically shown to significantly brighten skin, and address hyperpigmentation. Recent studies show that Lumixyl™, a chain of ten amino acids, treats hyperpigmentation more efficaciously than hydroquinone - the most commonly prescribed medication for the treatment of hyperpigmentation.
Envy is currently developing a rich portfolio of products and services around these exciting proprietary technologies.
(Health, Wellness and Fitness industry)
December 2007 — February 2009 (1 year 3 months)
Colorescience is a premium brand of OTC Powder sunscreens and physician dispensed cosmeceuticals. The Company was founded by Diane Ranger, who is also credited with the invention of mineral makeup in the late 70's when she founded Bare Escentuals. Their innovative all-powder sun screens under the Sunforgettable trademark are recommended by the Skin Cancer Foundation. Colorescience is available at dermatologist and plastic surgeon offices, as well as high-end resort and medical spas.
(Pharmaceuticals industry)
2002 — 2008 (6 years)
Obagi Medical Products, Inc. (the "Company") is a specialty pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems. The Company markets its products through its own sales force throughout the United States, and through 15 distribution partners in 39 other countries in regions including North America, Europe, the Far East, the Middle East, Central America, and South America. The Company also licenses certain non-prescription product concepts under the Obagi trademark to a large Japanese based pharmaceutical company for sale through consumer distribution channels in Japan.
(Public Company; Consumer Goods industry)
2000 — 2002 (2 years)
Beyond Corporation is a pioneer in online software sales and digital download technology. In 2002 the assets of the company were acquired by Digital RiverDigital River, Inc., currently a global leader in e-commerce outsourcing. The company’s comprehensive platform offers site development and hosting, order management, fraud prevention, export controls, tax management, physical and digital product fulfillment, multi-lingual customer service, advanced reporting and strategic marketing services.
(Public Company; 1001-5000 employees; MSEL; Consumer Goods industry)
1996 — 2000 (4 years)
Merisel Inc., was a fortun 500 wholesale distributor of Computer hardware and software, with sales in excess of $5 billion. The principal operating units were sold to Synnex, Inc. (Canadian distribution division) and Arrow Electronics (Sun Microsystems division), by the end of 2001. Proceeds from the sale of these operating units were used to launch Merisel's current focus on high-end graphic printing and production.
(Public Company; 10,001 or more employees; Industrial Automation industry)
1994 — 1996 (2 years)
Westburne Inc., is a multi-billion dollar wholesale distributor of commercial building materials. It is now part of Rexel S.A., the largest North American integrated wholesale distributor of construction, industrial and commercial supplies.
(Partnership; 10,001 or more employees; DTT; Accounting industry)
1991 — 1994 (3 years)
“Deloitte” is the brand under which tens of thousands of dedicated professionals in independent firms throughout the world collaborate to provide audit, consulting, financial advisory, risk management, and tax services to selected clients. These firms are members of Deloitte Touche Tohmatsu (“DTT”), a Swiss Verein.
BS , 1987 — 1991
AAD, GLG - Council of Advisors, Canada Halifax Mission Alumni